Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Nikolai V. Naoumov, Karsten Wursthorn et al.|Journal of Hepatology|2014Cited by 62
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infectionJean–Michel Pawlotsky, Robert Flisiak, Shiv Kumar Sarin et al.|Hepatology|2015Cited by 51
833 DOWN-REGULATION OF INTERFERON-STIMULATED GENES AFTER ALISPORIVIR INTERFERON-FREE TREATMENT SUGGESTS A UNIQUE ANTIVIRAL MECHANISM OF ACTION FOR ALISPORIVIR, A CYCLOPHILIN INHIBITORSilke K. Kaiser, B. Li, W. Bao et al.|Journal of Hepatology|2013Cited by 1
Sa1033 Interferon-Free Alisporivir Treatment Down-Regulates Interferon-Stimulated Genes Suggesting a Unique Antiviral Mechanism of Action for the Cyclophilin Inhibitor AlisporivirSergio Kaiser, Bin Li, Philippe Gallay et al.|Gastroenterology|2013Cited by 0